Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Dr. Baber is a Professor of Medicine and serves as the Cardiology Section Chief and Director of the Cardiac Catheterization Laboratory at the University of Oklahoma Health Sciences Center. Prior to joining the University of Oklahoma, Dr. Baber served as the Director of Cath Lab Quality and Outcomes Research within the Cardiovascular Institute at Mount Sinai Hospital in New York City. During his fellowship training he also earned a Master’s Degree in biostatistics from the Mailman School of Public Health at Columbia University. From a clinical standpoint Dr. Baber focuses on complex, high-risk coronary interventions. Research interests include clinical and translational projects related to bleeding, thrombosis and platelet function. He is a frequent lecturer at international cardiology conferences and serves on the Editorial Boards of numerous peer-reviewed journals.
Disclosure(s): Abbott Cardiovascular Systems: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
THROMBUS MANAGEMENT AND ANTICOAGULATION
Sunday, March 9, 2025
2:54 PM – 4:25 PM ET
Panel Discussion | Thrombus Management and Anticoagulation
Sunday, March 9, 2025
4:06 PM – 4:25 PM ET
Sunday, March 9, 2025
7:40 PM – 7:50 PM ET
Cangrelor as a Bridge to CABG and Which Antiplatelet Post Cangrelor?
Sunday, March 9, 2025
8:00 PM – 8:10 PM ET
Sunday, March 9, 2025
8:30 PM – 8:45 PM ET
LATE-BREAKING CLINICAL SCIENCE | CORONARY II
Monday, March 10, 2025
9:00 AM – 10:00 AM ET